Vaxcyte, Inc. ($PCVX)
Filing Information
| Accession Number | 0001960048-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
44,537
Total Value
$235,265.34
P&L
+inf% (+$1,561,512.75)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Finance & CAO | Common Stock | โ | Feb 26, 2026 | Grant/Award | 10,681 | $0.00 | $0.00 | 24,215 | Direct | โ | View Details | |
SVP, Finance & CAO | Common Stock | โ | Feb 26, 2026 | Exercise/Conversion | 7,716 | $25.92 | $199,998.72 | 31,931 | Direct | โ | View Details | |
SVP, Finance & CAO | Common Stock | โ | Feb 28, 2026 | Tax Withholding | 243 | $61.98 | $15,061.14 | 31,688 | Direct | โ | View Details | |
SVP, Finance & CAO | Common Stock | โ | Mar 2, 2026 | Tax Withholding | 326 | $61.98 | $20,205.48 | 31,362 | Direct | โ | View Details | |
SVP, Finance & CAO | Stock Option (right to buy) | Derivative | Feb 26, 2026 | Grant/Award | 17,855 | $0.00 | $0.00 | 17,855 | Direct | โ | View Details | |
SVP, Finance & CAO | Stock Option (right to buy) | Derivative | Feb 26, 2026 | Exercise/Conversion | 7,716 | $0.00 | $0.00 | 98,568 | Direct | โ | View Details |